The metabolic disequilibrium is further reinforced by VEGF and PGE2 secretion, which compromise local vascular perfusion and restrict nutrient delivery to immune cells, creating hypoxic immune “dead zones” in the tumor center [12,41,42]. The gene discussed is VEGFA; the disease is neoplasm.